Accuris Draft BS EN ISO 10993-17 :2023/Amd 1 Biological evaluation of medical devices. Part 17: Toxicological risk assessment of medical device constituents - Amendment 24/30482502 DC (DRAFT)

Description
Draft BS EN ISO 10993-17 :2023/Amd 1 Biological evaluation of medical devices. Part 17: Toxicological risk assessment of medical device constituents - Amendment
Request a Quote
Description
Draft BS EN ISO 10993-17 :2023/Amd 1 Biological evaluation of medical devices. Part 17: Toxicological risk assessment of medical device constituents - Amendment
Request a Quote

Suppliers

Company
Product
Description
Supplier Links
Draft BS EN ISO 10993-17 :2023/Amd 1 Biological evaluation of medical devices. Part 17: Toxicological risk assessment of medical device constituents - Amendment - 24/30482502 DC (DRAFT) - Accuris
Englewood, CO, United States
Draft BS EN ISO 10993-17 :2023/Amd 1 Biological evaluation of medical devices. Part 17: Toxicological risk assessment of medical device constituents - Amendment
24/30482502 DC (DRAFT)
Draft BS EN ISO 10993-17 :2023/Amd 1 Biological evaluation of medical devices. Part 17: Toxicological risk assessment of medical device constituents - Amendment 24/30482502 DC (DRAFT)
Draft BS EN ISO 10993-17 :2023/Amd 1 Biological evaluation of medical devices. Part 17: Toxicological risk assessment of medical device constituents - Amendment

Draft BS EN ISO 10993-17 :2023/Amd 1 Biological evaluation of medical devices. Part 17: Toxicological risk assessment of medical device constituents - Amendment

Buy Now

Technical Specifications

  Accuris
Product Category Standards and Technical Documents
Product Number 24/30482502 DC (DRAFT)
Product Name Draft BS EN ISO 10993-17 :2023/Amd 1 Biological evaluation of medical devices. Part 17: Toxicological risk assessment of medical device constituents - Amendment
Unlock Full Specs
to access all available technical data

Similar Products